Skip to content
  • Saturday, 12 September 2026
  • 5:49 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Eli Lilly Commits Up to $3.8 Billion to Acquire AtaiBeckley, Betting on the ‘God Molecule’ 5-MeO-DMT for Transformative Mental Healthcare
Laboratory Automation & Robotics

Eli Lilly Commits Up to $3.8 Billion to Acquire AtaiBeckley, Betting on the ‘God Molecule’ 5-MeO-DMT for Transformative Mental Healthcare

Lana Keisha Jul 24, 2026 0

Indianapolis, IN – Pharmaceutical giant Eli Lilly has announced a definitive agreement to acquire AtaiBeckley, a clinical-stage biotechnology company focused…

Read More
Laboratory Automation & Robotics

Pharma 50 2026: The top spot in pharma rarely lasts. Lilly is betting it can change that.

Lana Keisha May 4, 2026 0

Eli Lilly, a pharmaceutical giant that just last year occupied the ninth position, has ascended to the pinnacle of the…

Read More
Laboratory Automation & Robotics

Pharma 50 2026: The top spot in pharma rarely lasts. Lilly is betting it can change that.

Lana Keisha Apr 22, 2026 0

Eli Lilly has ascended to the pinnacle of the pharmaceutical industry, claiming the top spot in the prestigious Pharma 50…

Read More
Laboratory Automation & Robotics

Pharma 50 2026: The top spot in pharma rarely lasts. Lilly is betting it can change that.

Lana Keisha Apr 15, 2026 0

The pharmaceutical industry, known for its dynamic shifts and competitive landscape, has witnessed a seismic change at its pinnacle. Eli…

Read More
Laboratory Automation & Robotics

Pharma 50 2026: The top spot in pharma rarely lasts. Lilly is betting it can change that.

Lana Keisha Apr 7, 2026 0

Eli Lilly has ascended to the pinnacle of the pharmaceutical industry, claiming the top spot on the prestigious Pharma 50…

Read More
Laboratory Automation & Robotics

Pharma 50 2026: The top spot in pharma rarely lasts. Lilly is betting it can change that.

Lana Keisha Mar 31, 2026 0

Eli Lilly has made a historic leap, claiming the top position in the prestigious Pharma 50 ranking for 2026, a…

Read More
Science News Celebrates a Century of Empowering Public Understanding of Science, Medicine, and TechnologyTakara Bio Unveils Benchmarking Study Comparing Trekker FX with Visium HD and Xenium 5K for Spatial Transcriptomics in FFPE TissuesCEO of CDMO AustinPx on its exclusive agreement with Thermo Fisher’s Patheon divisionThe Power of Perspective: How Space Images Bridge the Vastness of the Cosmos
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
TWiV 1287: Ancient herpesviruses and modern dementiaJohns Hopkins Researchers Discover How Fusion Genes Drive Rare Kidney Cancer Through Liquid DropletsRNA breakthrough provides hope for thousands of untreatable diseases, including cystic fibrosis, muscular dystrophy and some cancersMerck and Moderna’s cancer vaccine is customized for each patient’s tumor
YOU MAY HAVE MISSED
Microbiology & Immunology
TWiV 1287: Ancient herpesviruses and modern dementia
Lina Irawan Sep 12, 2026
Stem Cell & Regenerative Medicine
Johns Hopkins Researchers Discover How Fusion Genes Drive Rare Kidney Cancer Through Liquid Droplets
Dwi Wanna Sep 12, 2026
Biotech & Genetic Research
RNA breakthrough provides hope for thousands of untreatable diseases, including cystic fibrosis, muscular dystrophy and some cancers
Jia Lissa Sep 12, 2026
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Sep 12, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ